These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23498162)

  • 1. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
    Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
    J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
    Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
    Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
    Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
    Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
    Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance and implications of capillaritis during acute rejection of kidney allografts.
    Cosio FG; Lager DJ; Lorenz EC; Amer H; Gloor JM; Stegall MD
    Transplantation; 2010 May; 89(9):1088-94. PubMed ID: 20216485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
    Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
    Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?
    Peng DM; Law YM; Kemna MS; Warner P; Nelson K; Boucek RJ
    Pediatr Transplant; 2013 Aug; 17(5):429-35. PubMed ID: 23551503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection.
    Hönger G; Wahrmann M; Amico P; Hopfer H; Böhmig GA; Schaub S
    Transplantation; 2010 Jun; 89(12):1471-5. PubMed ID: 20395886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection.
    Fedrigo M; Feltrin G; Poli F; Frigo AC; Benazzi E; Gambino A; Tona F; Caforio AL; Castellani C; Toscano G; Gerosa G; Thiene G; Angelini A
    J Heart Lung Transplant; 2013 Apr; 32(4):404-9. PubMed ID: 23498161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
    Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
    J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
    Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
    Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
    Frank R; Lal P; Kearns J; Molina MR; Wald JW; Goldberg LR; Kamoun M
    Am J Clin Pathol; 2016 Jan; 145(1):62-8. PubMed ID: 26712872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
    Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
    Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
    Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation.
    Xu Y; Galambos C; Reyes-Múgica M; Miller SA; Zeevi A; Webber SA; Feingold B
    J Heart Lung Transplant; 2013 Jan; 32(1):92-7. PubMed ID: 23260709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.
    Akalin E; Dinavahi R; Dikman S; de Boccardo G; Friedlander R; Schroppel B; Sehgal V; Bromberg JS; Heeger P; Murphy B
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1261-7. PubMed ID: 17942771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
    Mohamedali B; Pyle J; Bhat G
    Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.